Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 17, 2007

Primary Completion Date

June 5, 2008

Study Completion Date

June 5, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GSK189075

GSK189075 is available as a white, capsule-shaped tablet dosage form containing 50mg, 125mg, 250mg or 500mg of GSK189075 per tablet

DRUG

Placebo

Available as Placebo matching tablet to GSK189075

Trial Locations (157)

1459

GSK Investigational Site, Gauteng

1709

GSK Investigational Site, Roodepoort

3201

GSK Investigational Site, Rotorua

7011

GSK Investigational Site, Clifton

7505

GSK Investigational Site, Parow

7530

GSK Investigational Site, Bellville

10032

GSK Investigational Site, New York

10115

GSK Investigational Site, Berlin

10249

GSK Investigational Site, Berlin

11528

GSK Investigational Site, Athens

11725

GSK Investigational Site, Commack

12524

GSK Investigational Site, Berlin

13347

GSK Investigational Site, Berlin

13415

GSK Investigational Site, Tallinn

13419

GSK Investigational Site, Tallinn

14612

GSK Investigational Site, Falkensee

14850

GSK Investigational Site, Ithaca

19020

GSK Investigational Site, Bensalem/Pennsylvania

19382

GSK Investigational Site, West Chester

20745

GSK Investigational Site, Oxon Hill

21010

GSK Investigational Site, Vinnitsa

21255

GSK Investigational Site, Tostedt

21339

GSK Investigational Site, Lüneburg

22015

GSK Investigational Site, Burke

23568

GSK Investigational Site, Lübeck

27203

GSK Investigational Site, Asheboro/North Carolina

28816

GSK Investigational Site, Brinkum/Stuhr

29102

GSK Investigational Site, Manning

29681

GSK Investigational Site, Simpsonville

30159

GSK Investigational Site, Hanover

30322

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

32223

GSK Investigational Site, Jacksonville/Florida

32720

GSK Investigational Site, Deland/Florida

33023

GSK Investigational Site, Hollywood

33156

GSK Investigational Site, Miami

33169

GSK Investigational Site, Miami

34070

GSK Investigational Site, Durango

34761

GSK Investigational Site, Ocoee/Florida

34769

GSK Investigational Site, Saint Cloud

37303

GSK Investigational Site, Athens/Tennessee

37574

GSK Investigational Site, Einbeck

39090

GSK Investigational Site, Kosciusko

39159

GSK Investigational Site, Rolling Fork

39202

GSK Investigational Site, Jackson

39326

GSK Investigational Site, Wolmirstedt

39501

GSK Investigational Site, Gulfport

44150

GSK Investigational Site, Guadalajara

44614

GSK Investigational Site, Canal Fulton

46614

GSK Investigational Site, South Bend

49027

GSK Investigational Site, Dnipropetrovsk

51014

GSK Investigational Site, Tartu

55218

GSK Investigational Site, Ingelheim

56429

GSK Investigational Site, Thessaloniki

60108

GSK Investigational Site, Bloomingdale

60523

GSK Investigational Site, Oak Brook

60616

GSK Investigational Site, Chicago

62250

GSK Investigational Site, Cuernavaca

63017

GSK Investigational Site, Chesterfield

63118

GSK Investigational Site, Saint Louis/Missouri

67454

GSK Investigational Site, Haßloch

70503

GSK Investigational Site, Lafayette

70601

GSK Investigational Site, Lake Charles

75230

GSK Investigational Site, Dallas

75235

GSK Investigational Site, Dallas

77030

GSK Investigational Site, Houston

77074

GSK Investigational Site, Houston

77081

GSK Investigational Site, Houston

78221

GSK Investigational Site, San Anonio

78229

GSK Investigational Site, San Antonio

78404

GSK Investigational Site, Corpus Christi

78550

GSK Investigational Site, Harlingen/Texas

79705

GSK Investigational Site, Midland

80018

GSK Investigational Site, Pärnu

80339

GSK Investigational Site, Munich

80469

GSK Investigational Site, Munich

85206

GSK Investigational Site, Mesa

87102

GSK Investigational Site, Albuquerque

88239

GSK Investigational Site, Wangen

89014

GSK Investigational Site, Henderson

89016

GSK Investigational Site, Las Vegas

89106

GSK Investigational Site, Las Vegas

89119

GSK Investigational Site, Las Vegas

89128

GSK Investigational Site, Las Vegas

89604

GSK Investigational Site, Allmendingen

90505

GSK Investigational Site, Torrance

90620

GSK Investigational Site, Buena Park

90650

GSK Investigational Site, Norwalk

90701

GSK Investigational Site, Artesia

91356

GSK Investigational Site, Tarzana

92037

GSK Investigational Site, La Jolla

92237

GSK Investigational Site, Sulzbach-Rosenberg

92331

GSK Investigational Site, Parsberg

92701

GSK Investigational Site, Santa Ana

93720

GSK Investigational Site, Fresno

94239

GSK Investigational Site, Ruhmannsfelden

94401

GSK Investigational Site, San Mateo

94545

GSK Investigational Site, Hohenau

94550

GSK Investigational Site, Künzing

94904

GSK Investigational Site, Greenbrae

94954

GSK Investigational Site, Petaluma

95823

GSK Investigational Site, Sacramento

96269

GSK Investigational Site, Großheirath

97129

GSK Investigational Site, Mérida

98004

GSK Investigational Site, Bellevue

129110

GSK Investigational Site, Moscow

191025

GSK Investigational Site, Saint Petersburg

197022

GSK Investigational Site, Saint-Peterburgh

300736

GSK Investigational Site, Timișoara

310011

GSK Investigational Site, Arad

400007

GSK Investigational Site, Mumbai

411004

GSK Investigational Site, Pune

500365

GSK Investigational Site, Brasov

520064

GSK Investigational Site, Sfântu Gheorghe

560034

GSK Investigational Site, Bangalore

560043

GSK Investigational Site, Bangalore

600010

GSK Investigational Site, Chennai

625023

GSK Investigational Site, Tyumen

02118

GSK Investigational Site, Boston

V3A 4H9

GSK Investigational Site, Langley

E2A 4X7

GSK Investigational Site, Bathurst

A0A 1G0

GSK Investigational Site, Bay Roberts

L6T 3T1

GSK Investigational Site, Brampton

L5A 3V4

GSK Investigational Site, Mississauga

L6H 3P1

GSK Investigational Site, Oakville

K1K 4K4

GSK Investigational Site, Ottawa

L4J 8L7

GSK Investigational Site, Thornhill

M3H 5S4

GSK Investigational Site, Toronto

M4R 2G4

GSK Investigational Site, Toronto

G2E 2X1

GSK Investigational Site, L'Ancienne-Lorette

G1V 4G5

GSK Investigational Site, Québec

624 00

GSK Investigational Site, Brno

636 00

GSK Investigational Site, Brno

100 00

GSK Investigational Site, Prague

158 00

GSK Investigational Site, Prague

01129

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

01762

GSK Investigational Site, Schmiedeberg

115 27

GSK Investigational Site, Athens

564 29

GSK Investigational Site, Thessaloniki

LT-48259

GSK Investigational Site, Kaunas

LT-50009

GSK Investigational Site, Kaunas

LT-51270

GSK Investigational Site, Kaunas

LT-08661

GSK Investigational Site, Vilnius

85-021

GSK Investigational Site, Bydgoszcz

43-353

GSK Investigational Site, Porąbka

41-103

GSK Investigational Site, Siemianowice Śląskie

50-349

GSK Investigational Site, Wroclaw

00705

GSK Investigational Site, Aibonito/Puerto Rico

00976

GSK Investigational Site, Trujillo Alto/Puerto Rico

00725

GSK Investigational Site, Caguas

00983

GSK Investigational Site, Carolina

00717

GSK Investigational Site, Ponce

00921

GSK Investigational Site, Rio Piedras

634 050

GSK Investigational Site, Tomsk

01827

GSK Investigational Site, Lenasia South

02091

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00495469 - Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive | Biotech Hunter | Biotech Hunter